Blog .

NEOS Surgery wins 1.9M€ funding of the EIC Accelerator

Life Sciences

We are happy to announce that our colleagues from NEOS Surgery have received a total of 1.9M€ funding from the EIC Accelerator (ex SME Instrument Phase 2). Thanks to this funding, the company can now clinically validate the DISC care™ device, which has been designed to respond to lumbar disc herniation. Moreover, this funding ensures the rise of a new round of private funding that will allow the technology to reach patients.

NEOS Surgery is a high-tech SME dedicated to the development, manufacturing and commercialization of medical devices for neurosurgery (which includes surgery of the brain, nerves and spine). NEOS aims to enter the dynamic and high-volumen Spinal Surgery market. Its objective is to complete the clinical study of Disc care™ in five Spanish university hospitals during 2021. Subsequently, it will enter the regulatory phase in Europe and the United Statets and begin marketing of the product in 2023.

At Inveniam Group, we are glad to have contributed to the company’s success. We wish you good luck for the continuation of your projects.

Read this article for more information.